Bristol-Myers Squibb Co. Reaches New 12-Month High at $54.76 (BMY)
Bristol-Myers Squibb (NYSE:BMY)’s share price reached a new 52-week high on Thursday, AnalystRatings.NET reports. The company traded as high as $54.76 and last traded at $54.73, with a volume of 6,506,679 shares traded. The stock had previously closed at $53.42.
A number of analysts have recently weighed in on BMY shares. Analysts at TheStreet reiterated a “buy” rating on shares of Bristol-Myers Squibb in a research note to investors on Thursday. Separately, analysts at Jefferies Group raised their price target on shares of Bristol-Myers Squibb from $48.00 to $50.00 in a research note to investors on Thursday. They now have a “hold” rating on the stock. Finally, analysts at Credit Suisse reiterated an “outperform” rating on shares of Bristol-Myers Squibb in a research note to investors on Friday, December 20th. They now have a $60.00 price target on the stock, up previously from $56.00. One investment analyst has rated the stock with a sell rating, seven have assigned a hold rating, eleven have assigned a buy rating and one has given a strong buy rating to the company. The company currently has a consensus rating of “Buy” and an average target price of $51.43.
Bristol-Myers Squibb has a 52 week low of $33.69 and a 52 week high of $54.49. The stock has a 50-day moving average of $52.12 and a 200-day moving average of $47.54. The company has a market cap of $90.510 billion and a P/E ratio of 32.06.
Bristol-Myers Squibb (NYSE:BMY) last issued its quarterly earnings data on Wednesday, October 23rd. The company reported $0.46 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.44 by $0.02. The company had revenue of $4.07 billion for the quarter, compared to the consensus estimate of $4.02 billion. During the same quarter in the previous year, the company posted $0.41 earnings per share. The company’s revenue for the quarter was up 8.8% on a year-over-year basis. On average, analysts predict that Bristol-Myers Squibb will post $1.75 earnings per share for the current fiscal year.
The company also recently announced a quarterly dividend, which is scheduled for Monday, February 3rd. Stockholders of record on Friday, January 3rd will be paid a dividend of 0.36 per share. This represents a $1.44 annualized dividend and a dividend yield of 2.70%. The ex-dividend date is Tuesday, December 31st. This is a boost from Bristol-Myers Squibb’s previous quarterly dividend of $0.35.
Bristol-Myers Squibb Company (NYSE:BMY) is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products on a global basis.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.